Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report

Multiple primary malignancies can occur in the same organ or in multiple organs or systems. Likewise, they can occur simultaneously or successively. Based on the timing of the diagnosis, they are classified as multiple synchronous (i.e., concurrent) or metachronous (i.e., successive) primary maligna...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore) 2018-06, Vol.97 (24), p.e11107-e11107
Hauptverfasser: Song, Liang, Li, Qingli, Yang, Kaixuan, Yin, Rutie, Wang, Danqing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e11107
container_issue 24
container_start_page e11107
container_title Medicine (Baltimore)
container_volume 97
creator Song, Liang
Li, Qingli
Yang, Kaixuan
Yin, Rutie
Wang, Danqing
description Multiple primary malignancies can occur in the same organ or in multiple organs or systems. Likewise, they can occur simultaneously or successively. Based on the timing of the diagnosis, they are classified as multiple synchronous (i.e., concurrent) or metachronous (i.e., successive) primary malignancies. The vast majority of patients have multiple metachronous malignant tumors; multiple synchronous tumors are rare. A 63-year-old woman presented with the chief complaint of vaginal fluid discharge for 3 months and abdominal pain for 1 month. The patient was diagnosed with multiple synchronous primary malignancies: 1) endometrial poorly differentiated serous adenocarcinoma, stage IV; 2) poorly differentiated squamous cell carcinoma of the cervix, stage IB1; and 3) left-sided fallopian tube carcinoma in situ. After total abdominal hysterectomy, bilateral salpingo-oophorectomy, and comprehensive staging and debulking, the patient was administered eight courses of adjuvant chemotherapy (taxane carboplatin/taxane cisplatin). After chemotherapy completion, the patient has been undergoing regular follow-up examinations; no recurrence has been noted at 18 months. It is important to distinguish between multiple synchronous primary malignancies and metastasis of a primary tumor to select the appropriate treatment regimen and to adequately assess the patient's prognosis. When a cancer patient shows clinical manifestations of another tumor, not only metastasis but also the possibility of multiple synchronous primary malignant tumors should be considered. The duration of follow-up in patients with malignant tumors should be extended as much as possible, as the timely detection and treatment of other primary malignant tumors can prolong survival and improve the quality of life.
doi_str_mv 10.1097/MD.0000000000011107
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6024067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2055614315</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3558-216d58644d68cb017e8a46b96e12f91abae718c25babce761ca6435fffc4a3403</originalsourceid><addsrcrecordid>eNpdUU1v1DAQtRCILgu_AAn5yKEp_nbCAalqoUVq1Us5WxPvpAl47cVO-vHvSbtLC53LSDNv3sy8R8h7zg44a-yn8-MD9hScc2ZfkAXX0lS6MeolWTAmdGUbq_bIm1J-ziBphXpN9kTTMG4kWxB32WdEusnDGvIdLXfR9znFNBW6hjBcRYh-wEJTR8ce6TRinso-9Zivh9t9CnFFOwghbQaIdJxa_EwPqYeCNOMm5fEteTX3C77b5SX58e3r5dFpdXZx8v3o8KzyUuu6EtysdG2UWpnat4xbrEGZtjHIRddwaAEtr73QLbQereEejJK66zqvQComl-TLlncztWtceYxjhuB2f7kEg_u_E4feXaVrZ5hQzNiZ4OOOIKffE5bRrYfiMQSIOKvhBNPacCVnfZdEbqE-p1Iydo9rOHP31rjzY_fcmnnqw78XPs789WIGqC3gJoVZ5vIrTDeYXY8Qxv6BT9tGVILxmhmuWXVfqeUfMYOanA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2055614315</pqid></control><display><type>article</type><title>Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wolters Kluwer Open Health</source><source>IngentaConnect Free/Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Song, Liang ; Li, Qingli ; Yang, Kaixuan ; Yin, Rutie ; Wang, Danqing</creator><creatorcontrib>Song, Liang ; Li, Qingli ; Yang, Kaixuan ; Yin, Rutie ; Wang, Danqing</creatorcontrib><description>Multiple primary malignancies can occur in the same organ or in multiple organs or systems. Likewise, they can occur simultaneously or successively. Based on the timing of the diagnosis, they are classified as multiple synchronous (i.e., concurrent) or metachronous (i.e., successive) primary malignancies. The vast majority of patients have multiple metachronous malignant tumors; multiple synchronous tumors are rare. A 63-year-old woman presented with the chief complaint of vaginal fluid discharge for 3 months and abdominal pain for 1 month. The patient was diagnosed with multiple synchronous primary malignancies: 1) endometrial poorly differentiated serous adenocarcinoma, stage IV; 2) poorly differentiated squamous cell carcinoma of the cervix, stage IB1; and 3) left-sided fallopian tube carcinoma in situ. After total abdominal hysterectomy, bilateral salpingo-oophorectomy, and comprehensive staging and debulking, the patient was administered eight courses of adjuvant chemotherapy (taxane carboplatin/taxane cisplatin). After chemotherapy completion, the patient has been undergoing regular follow-up examinations; no recurrence has been noted at 18 months. It is important to distinguish between multiple synchronous primary malignancies and metastasis of a primary tumor to select the appropriate treatment regimen and to adequately assess the patient's prognosis. When a cancer patient shows clinical manifestations of another tumor, not only metastasis but also the possibility of multiple synchronous primary malignant tumors should be considered. The duration of follow-up in patients with malignant tumors should be extended as much as possible, as the timely detection and treatment of other primary malignant tumors can prolong survival and improve the quality of life.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000011107</identifier><identifier>PMID: 29901630</identifier><language>eng</language><publisher>United States: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Carcinoma, Endometrioid - drug therapy ; Carcinoma, Endometrioid - pathology ; Carcinoma, Squamous Cell - drug therapy ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - surgery ; Cervix Uteri - pathology ; Chemotherapy, Adjuvant - methods ; Clinical Case Report ; Endometrial Neoplasms - drug therapy ; Endometrial Neoplasms - pathology ; Endometrial Neoplasms - surgery ; Fallopian Tube Neoplasms - drug therapy ; Fallopian Tube Neoplasms - pathology ; Fallopian Tube Neoplasms - surgery ; Fallopian Tubes - pathology ; Female ; Humans ; Hysterectomy - methods ; Middle Aged ; Neoplasms, Multiple Primary - drug therapy ; Neoplasms, Multiple Primary - pathology ; Neoplasms, Multiple Primary - surgery ; Salpingo-oophorectomy - methods ; Uterine Cervical Neoplasms - drug therapy ; Uterine Cervical Neoplasms - pathology ; Uterine Cervical Neoplasms - surgery ; Uterus - pathology</subject><ispartof>Medicine (Baltimore), 2018-06, Vol.97 (24), p.e11107-e11107</ispartof><rights>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><rights>Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3558-216d58644d68cb017e8a46b96e12f91abae718c25babce761ca6435fffc4a3403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024067/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024067/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,862,883,27911,27912,53778,53780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29901630$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Song, Liang</creatorcontrib><creatorcontrib>Li, Qingli</creatorcontrib><creatorcontrib>Yang, Kaixuan</creatorcontrib><creatorcontrib>Yin, Rutie</creatorcontrib><creatorcontrib>Wang, Danqing</creatorcontrib><title>Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>Multiple primary malignancies can occur in the same organ or in multiple organs or systems. Likewise, they can occur simultaneously or successively. Based on the timing of the diagnosis, they are classified as multiple synchronous (i.e., concurrent) or metachronous (i.e., successive) primary malignancies. The vast majority of patients have multiple metachronous malignant tumors; multiple synchronous tumors are rare. A 63-year-old woman presented with the chief complaint of vaginal fluid discharge for 3 months and abdominal pain for 1 month. The patient was diagnosed with multiple synchronous primary malignancies: 1) endometrial poorly differentiated serous adenocarcinoma, stage IV; 2) poorly differentiated squamous cell carcinoma of the cervix, stage IB1; and 3) left-sided fallopian tube carcinoma in situ. After total abdominal hysterectomy, bilateral salpingo-oophorectomy, and comprehensive staging and debulking, the patient was administered eight courses of adjuvant chemotherapy (taxane carboplatin/taxane cisplatin). After chemotherapy completion, the patient has been undergoing regular follow-up examinations; no recurrence has been noted at 18 months. It is important to distinguish between multiple synchronous primary malignancies and metastasis of a primary tumor to select the appropriate treatment regimen and to adequately assess the patient's prognosis. When a cancer patient shows clinical manifestations of another tumor, not only metastasis but also the possibility of multiple synchronous primary malignant tumors should be considered. The duration of follow-up in patients with malignant tumors should be extended as much as possible, as the timely detection and treatment of other primary malignant tumors can prolong survival and improve the quality of life.</description><subject>Carcinoma, Endometrioid - drug therapy</subject><subject>Carcinoma, Endometrioid - pathology</subject><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Cervix Uteri - pathology</subject><subject>Chemotherapy, Adjuvant - methods</subject><subject>Clinical Case Report</subject><subject>Endometrial Neoplasms - drug therapy</subject><subject>Endometrial Neoplasms - pathology</subject><subject>Endometrial Neoplasms - surgery</subject><subject>Fallopian Tube Neoplasms - drug therapy</subject><subject>Fallopian Tube Neoplasms - pathology</subject><subject>Fallopian Tube Neoplasms - surgery</subject><subject>Fallopian Tubes - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Hysterectomy - methods</subject><subject>Middle Aged</subject><subject>Neoplasms, Multiple Primary - drug therapy</subject><subject>Neoplasms, Multiple Primary - pathology</subject><subject>Neoplasms, Multiple Primary - surgery</subject><subject>Salpingo-oophorectomy - methods</subject><subject>Uterine Cervical Neoplasms - drug therapy</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Uterine Cervical Neoplasms - surgery</subject><subject>Uterus - pathology</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUU1v1DAQtRCILgu_AAn5yKEp_nbCAalqoUVq1Us5WxPvpAl47cVO-vHvSbtLC53LSDNv3sy8R8h7zg44a-yn8-MD9hScc2ZfkAXX0lS6MeolWTAmdGUbq_bIm1J-ziBphXpN9kTTMG4kWxB32WdEusnDGvIdLXfR9znFNBW6hjBcRYh-wEJTR8ce6TRinso-9Zivh9t9CnFFOwghbQaIdJxa_EwPqYeCNOMm5fEteTX3C77b5SX58e3r5dFpdXZx8v3o8KzyUuu6EtysdG2UWpnat4xbrEGZtjHIRddwaAEtr73QLbQereEejJK66zqvQComl-TLlncztWtceYxjhuB2f7kEg_u_E4feXaVrZ5hQzNiZ4OOOIKffE5bRrYfiMQSIOKvhBNPacCVnfZdEbqE-p1Iydo9rOHP31rjzY_fcmnnqw78XPs789WIGqC3gJoVZ5vIrTDeYXY8Qxv6BT9tGVILxmhmuWXVfqeUfMYOanA</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Song, Liang</creator><creator>Li, Qingli</creator><creator>Yang, Kaixuan</creator><creator>Yin, Rutie</creator><creator>Wang, Danqing</creator><general>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180601</creationdate><title>Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report</title><author>Song, Liang ; Li, Qingli ; Yang, Kaixuan ; Yin, Rutie ; Wang, Danqing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3558-216d58644d68cb017e8a46b96e12f91abae718c25babce761ca6435fffc4a3403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Carcinoma, Endometrioid - drug therapy</topic><topic>Carcinoma, Endometrioid - pathology</topic><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Cervix Uteri - pathology</topic><topic>Chemotherapy, Adjuvant - methods</topic><topic>Clinical Case Report</topic><topic>Endometrial Neoplasms - drug therapy</topic><topic>Endometrial Neoplasms - pathology</topic><topic>Endometrial Neoplasms - surgery</topic><topic>Fallopian Tube Neoplasms - drug therapy</topic><topic>Fallopian Tube Neoplasms - pathology</topic><topic>Fallopian Tube Neoplasms - surgery</topic><topic>Fallopian Tubes - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Hysterectomy - methods</topic><topic>Middle Aged</topic><topic>Neoplasms, Multiple Primary - drug therapy</topic><topic>Neoplasms, Multiple Primary - pathology</topic><topic>Neoplasms, Multiple Primary - surgery</topic><topic>Salpingo-oophorectomy - methods</topic><topic>Uterine Cervical Neoplasms - drug therapy</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Uterine Cervical Neoplasms - surgery</topic><topic>Uterus - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, Liang</creatorcontrib><creatorcontrib>Li, Qingli</creatorcontrib><creatorcontrib>Yang, Kaixuan</creatorcontrib><creatorcontrib>Yin, Rutie</creatorcontrib><creatorcontrib>Wang, Danqing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, Liang</au><au>Li, Qingli</au><au>Yang, Kaixuan</au><au>Yin, Rutie</au><au>Wang, Danqing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2018-06-01</date><risdate>2018</risdate><volume>97</volume><issue>24</issue><spage>e11107</spage><epage>e11107</epage><pages>e11107-e11107</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>Multiple primary malignancies can occur in the same organ or in multiple organs or systems. Likewise, they can occur simultaneously or successively. Based on the timing of the diagnosis, they are classified as multiple synchronous (i.e., concurrent) or metachronous (i.e., successive) primary malignancies. The vast majority of patients have multiple metachronous malignant tumors; multiple synchronous tumors are rare. A 63-year-old woman presented with the chief complaint of vaginal fluid discharge for 3 months and abdominal pain for 1 month. The patient was diagnosed with multiple synchronous primary malignancies: 1) endometrial poorly differentiated serous adenocarcinoma, stage IV; 2) poorly differentiated squamous cell carcinoma of the cervix, stage IB1; and 3) left-sided fallopian tube carcinoma in situ. After total abdominal hysterectomy, bilateral salpingo-oophorectomy, and comprehensive staging and debulking, the patient was administered eight courses of adjuvant chemotherapy (taxane carboplatin/taxane cisplatin). After chemotherapy completion, the patient has been undergoing regular follow-up examinations; no recurrence has been noted at 18 months. It is important to distinguish between multiple synchronous primary malignancies and metastasis of a primary tumor to select the appropriate treatment regimen and to adequately assess the patient's prognosis. When a cancer patient shows clinical manifestations of another tumor, not only metastasis but also the possibility of multiple synchronous primary malignant tumors should be considered. The duration of follow-up in patients with malignant tumors should be extended as much as possible, as the timely detection and treatment of other primary malignant tumors can prolong survival and improve the quality of life.</abstract><cop>United States</cop><pub>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>29901630</pmid><doi>10.1097/MD.0000000000011107</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2018-06, Vol.97 (24), p.e11107-e11107
issn 0025-7974
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6024067
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wolters Kluwer Open Health; IngentaConnect Free/Open Access Journals; PubMed Central; Alma/SFX Local Collection
subjects Carcinoma, Endometrioid - drug therapy
Carcinoma, Endometrioid - pathology
Carcinoma, Squamous Cell - drug therapy
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - surgery
Cervix Uteri - pathology
Chemotherapy, Adjuvant - methods
Clinical Case Report
Endometrial Neoplasms - drug therapy
Endometrial Neoplasms - pathology
Endometrial Neoplasms - surgery
Fallopian Tube Neoplasms - drug therapy
Fallopian Tube Neoplasms - pathology
Fallopian Tube Neoplasms - surgery
Fallopian Tubes - pathology
Female
Humans
Hysterectomy - methods
Middle Aged
Neoplasms, Multiple Primary - drug therapy
Neoplasms, Multiple Primary - pathology
Neoplasms, Multiple Primary - surgery
Salpingo-oophorectomy - methods
Uterine Cervical Neoplasms - drug therapy
Uterine Cervical Neoplasms - pathology
Uterine Cervical Neoplasms - surgery
Uterus - pathology
title Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T15%3A33%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Three%20primary%20synchronous%20malignancies%20of%20the%20uterus,%20cervix,%20and%20fallopian%20tube:%20A%20case%20report&rft.jtitle=Medicine%20(Baltimore)&rft.au=Song,%20Liang&rft.date=2018-06-01&rft.volume=97&rft.issue=24&rft.spage=e11107&rft.epage=e11107&rft.pages=e11107-e11107&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000011107&rft_dat=%3Cproquest_pubme%3E2055614315%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2055614315&rft_id=info:pmid/29901630&rfr_iscdi=true